Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bradley L. Campbell currently holds 998,680 shares of AMICUS THERAPEUTICS, INC. (FOLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bradley L. Campbell has been a net seller of FOLD stock. They have purchased $201.3K and sold $13.6M worth of shares.
Bradley L. Campbell's most recent insider trade was on Mar 2, 2026, when they sold 22,500 shares at $14.35 per share.
Bradley L. Campbell serves as Executive at AMICUS THERAPEUTICS, INC. (FOLD). They have executed 252 insider transactions totaling $13.8M over their tenure at the company.
Bradley L. Campbell holds the position of Executive at AMICUS THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Bradley L. Campbell has shown a selling trading pattern, with $201.3K in total purchases and $13.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bradley L. Campbell was on Dec 26, 2025, when they sold $1.5M worth of FOLD shares. This transaction involved 108,602 shares at $14.25 per share.
Bradley L. Campbell currently owns 998,680 shares of AMICUS THERAPEUTICS, INC. (FOLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bradley L. Campbell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bradley L. Campbell has 252 Form 4 filings on record as an insider at AMICUS THERAPEUTICS, INC..
Set alerts for Bradley L. Campbell and 40,000+ other insiders.